Methylated genes as new cancer biomarkers.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  European Journal of Cancer

• Publication date

  2009-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ejca.2008.12.008PMID 19138839
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epigenetics in cancer.

  2010influential reference
• DNA Methylation Markers Predict Outcome in Node-Positive, Estrogen Receptor-Positive Breast Cancer with Adjuvant Anthracycline-Based Chemotherapy

  2009cited by this paper
• Nonpegylated Liposomal Doxorubicin (TLC-D99), Paclitaxel, and Trastuzumab in HER-2-Overexpressing Breast Cancer: A Multicenter Phase I/II Study

  2009cited by this paper
• The use of genomic tools for the molecular understanding of breast cancer and to guide personalized medicine.

  2008cited by this paper
• A personalized approach to cancer treatment: how biomarkers can help.

  2008cited by this paper
• DNA methylation biomarkers for blood-based colorectal cancer screening.

  2008cited by this paper
• Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients.

  2008cited by this paper
• DNA methylation markers and early recurrence in stage I lung cancer.

  2008cited by this paper
• Quantitative promoter methylation analysis of hepatocellular carcinoma, cirrhotic and normal liver

  2008cited by this paper
• DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients

  2008cited by this paper
• Malignant gliomas in adults.

  2008cited by this paper
• Prostate-specific antigen and prostate cancer: prediction, detection and monitoring

  2008cited by this paper
• Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design

  2008cited by this paper
• Epigenetics in cancer.

  2008cited by this paper
• Translating insights from the cancer genome into clinical practice

  2008cited by this paper
• Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools.

  2007cited by this paper
• Molecular Detection of Localized Prostate Cancer Using Quantitative Methylation-Specific PCR on Urinary Cells Obtained Following Prostate Massage

  2007cited by this paper
• The epigenomics of cancer.

  2007influential reference
• Sequential gene promoter methylation during HPV-induced cervical carcinogenesis

  2007cited by this paper
• Age-Related DNA Methylation Changes in Normal Human Prostate Tissues

  2007influential reference
• DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and

  2007influential reference
• Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvements

  2007cited by this paper
• High-throughput methylation profiling by MCA coupled to CpG island microarray.

  2007cited by this paper
• Clinical Chemistry 53:12 2119–2127 (2007) Cancer Diagnostics MS-FLAG, a Novel Real-Time Signal Generation Method for Methylation-Specific PCR

  2007cited by this paper
• Role of tumor markers in patients with solid cancers: A critical review.

  2007cited by this paper
• Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing.

  2007cited by this paper
• Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.

  2006cited by this paper
• [Cancer epigenetics].

  2006cited by this paper
• Novel method for high throughput DNA methylation marker evaluation using PNA-probe library hybridization and MALDI-TOF detection

  2006cited by this paper
• Methylation of Serum DNA Is an Independent Prognostic Marker in Colorectal Cancer

  2006cited by this paper
• Epigenomics: Mapping the Methylome

  2006cited by this paper
• Combination of methylated-DNA precipitation and methylation-sensitive restriction enzymes (COMPARE-MS) for the rapid, sensitive and quantitative detection of DNA methylation

  2006cited by this paper
• Rapid and sensitive detection of CpG-methylation using methyl-binding (MB)-PCR

  2006cited by this paper
• MIRA-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells.

  2006cited by this paper
• Preoperative Serum DNA GSTP1 CpG Island Hypermethylation and the Risk of Early Prostate-Specific Antigen Recurrence Following Radical Prostatectomy

  2005cited by this paper
• MGMT gene silencing and benefit from temozolomide in glioblastoma.

  2005cited by this paper
• Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.

  2005influential reference
• Cancer epigenetics.

  2005cited by this paper
• Predictive markers in breast and other cancers: a review.

  2005cited by this paper
• Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk.

  2005influential reference
• Detection of hypermethylated genes in women with and without cervical neoplasia.

  2005cited by this paper
• Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps.

  2005cited by this paper
• Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer.

  2005cited by this paper
• Methylation of p15(INK4b) and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia.

  2005cited by this paper
• Epigenetic changes in prostate cancer: implication for diagnosis and treatment.

  2005cited by this paper
• Methylation of p15INK4b and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia

  2005cited by this paper
• Methylation Profiling of Archived Non–Small Cell Lung Cancer: A Promising Prognostic System

  2005cited by this paper
• Promoter Hypermethylation as an Independent Prognostic Factor for Relapse in Patients with Prostate Cancer Following Radical Prostatectomy

  2005cited by this paper
• Cancer genes and the pathways they control

  2004cited by this paper
• Detection of Methylated Apoptosis-Associated Genes in Urine Sediments of Bladder Cancer Patients

  2004cited by this paper
• Detection of Breast Cancer in Nipple Aspirate Fluid by CpG Island Hypermethylation

  2004cited by this paper
• A Quantitative Promoter Methylation Profile of Prostate Cancer

  2004cited by this paper
• Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma.

  2004cited by this paper
• Gene-promoter hypermethylation as a biomarker in lung cancer

  2004cited by this paper
• Prostate‐specific antigen: A review of the validation of the most commonly used cancer biomarker

  2004cited by this paper
• CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use

  2004cited by this paper
• Methylation changes in faecal DNA: a marker for colorectal cancer screening?

  2004cited by this paper
• Tumor Suppressor Gene Promoter Hypermethylation in Serum of Breast Cancer Patients

  2004cited by this paper
• A real-time PCR assay for DNA-methylation using methylation-specific blockers.

  2004cited by this paper
• Detection of Bladder Cancer in Urine by a Tumor Suppressor Gene Hypermethylation Panel

  2004cited by this paper
• Tumor Cell-Specific BRCA1 and RASSF1A Hypermethylation in Serum, Plasma, and Peritoneal Fluid from Ovarian Cancer Patients

  2004cited by this paper
• The economic impact of false-positive cancer screens.

  2004cited by this paper
• Association of Breast Cancer DNA Methylation Profiles with Hormone Receptor Status and Response to Tamoxifen

  2004cited by this paper
• Early detection: The power and the promise of DNA methylation markers

  2003influential reference
• Methyl‐CpG binding proteins identify novel sites of epigenetic inactivation in human cancer

  2003cited by this paper
• A systematic profile of DNA methylation in human cancer cell lines.

  2003cited by this paper
• Considerations on development, validation, application, and quality control of immuno(metric) biomarker assays in clinical cancer research: an EORTC-NCI working group report.

  2003cited by this paper
• Cancer epigenetics

  2003cited by this paper
• Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome.

  2003cited by this paper
• Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients

  2003cited by this paper
• Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: Time for large‐scale clinical studies?

  2003cited by this paper
• Study of suboptimum treatment response: lessons from breast cancer.

  2003cited by this paper
• Evaluation of a potential epigenetic biomarker by quantitative methyl‐single nucleotide polymorphism analysis

  2002cited by this paper
• DNA alterations in body fluids as molecular tumor markers for urological malignancies.

  2002cited by this paper
• DNA methylation and environmental exposures in human hepatocellular carcinoma.

  2002cited by this paper
• DNA methylation: a profile of methods and applications.

  2002cited by this paper
• DNA methylation and breast carcinogenesis

  2002cited by this paper
• Rules for making human tumor cells.

  2002cited by this paper
• Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma.

  2002cited by this paper
• Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer.

  2001cited by this paper
• DNA-based detection of prostate cancer in urine after prostatic massage.

  2001cited by this paper
• Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma.

  2001cited by this paper
• Adenocarcinoma Epigenetic Patterns in the Progression of Esophageal Updated Version

  2001cited by this paper
• Phases of biomarker development for early detection of cancer.

  2001cited by this paper
• A gene hypermethylation profile of human cancer.

  2001cited by this paper
• Tumour class prediction and discovery by microarray-based DNA methylation analysis.

  2001cited by this paper
• Serum Tumor Markers: Past, State of the Art, and Future

  2001cited by this paper
• p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium.

  2001cited by this paper
• Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer

  2001cited by this paper
• Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.

  2000cited by this paper
• Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status.

  2000cited by this paper
• Differential frequencies of p16(INK4a) promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers.

  2000cited by this paper
• Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer.

  2000cited by this paper
• Predicting lung cancer by detecting aberrant promoter methylation in sputum.

  2000cited by this paper
• Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer.

  2000cited by this paper
• Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids.

  2000cited by this paper
• Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1.

  2000cited by this paper
• Prognostic evaluation of primary non-small cell lung carcinoma patients using biological fluid variables. A systematic review

  2000cited by this paper
• Repair of O6-alkylguanine by alkyltransferases

  2000cited by this paper
• p53 and human cancer: the first ten thousand mutations.

  2000cited by this paper

• Identification and validation of blood leukocyte DNA methylation biomarkers for early detection of colorectal neoplasm.

  2025cites this paper
• Noninvasive early diagnosis of laryngeal squamous cell carcinoma (LSCC) revealing the high-performance potential of the HOXD10 gene monomethylated locus: a case–control study

  2025cites this paper
• Sensing, Imaging, and Therapeutic Strategies Endowing by Conjugate Polymers for Precision Medicine

  2024cites this paper
• The repertoire of mutational signatures in tobacco- and non-tobacco-induced oral cancer

  2023cites this paper
• The Association of Methylation Status and Expression Level of MyoD1 with DNMT1 Expression Level in Breast Cancer Patients

  2023cites this paper
• Liquid Biopsy in Cancer: Focus on Lymphoproliferative Disorders

  2022cites this paper
• Paradoxical effects of obesity on pre‑ vs. post‑menopausal breast cancer: The epigenetic mechanisms (Review)

  2021cites this paper
• Peripheral blood BRCA1 methylation profiling to predict familial ovarian cancer

  2021cites this paper
• CAMK2N1/RUNX3 methylation is an independent prognostic biomarker for progression-free and overall survival of platinum-sensitive epithelial ovarian cancer patients

  2021cites this paper
• Quantifying procedural pain associated with office gynecologic tract sampling methods.

  2021cites this paper
• VALD-3 inhibits proliferation and induces apoptosis of colorectal cancer cells via upregulating tumor suppressor activity of p53 to inhibit Wnt/β-catenin signal pathway

  2021cites this paper
• The Diagnostic and Prognostic Value of a Liquid Biopsy for Esophageal Cancer: A Systematic Review and Meta-Analysis

  2020cites this paper
• APC Promoter Hypermethylation as a Prognostic Marker in Breast Cancer Patients

  2020cites this paper
• Establishment of a RESEARCH USE ONLY Condensed-Efficient-Fast (CEF) PITX2 workflow for analysis of PITX2 DNA methylation in small tumor tissue samples 

  2020cites this paper
• FOXD3, frequently methylated in colorectal cancer, acts as a tumor suppressor and induces tumor cell apoptosis under ER stress via p53.

  2019cites this paper
• Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer

  2019cites this paper
• Detection and manipulation of methylation in blood cancer DNA using terahertz radiation

  2019cites this paper
• The Reprimo Gene Family: A Novel Gene Lineage in Gastric Cancer with Tumor Suppressive Properties

  2018cites this paper
• Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients

  2018cites this paper
• The anti-tumor effects of Mfn2 in breast cancer are dependent on promoter DNA methylation, the P21Ras motif and PKA phosphorylation site.

  2018cites this paper
• therascreenPITX2 RGQ PCR assay for the assessment of PITX2 DNA-methylation status to investigate the role of the transcription factor PITX2 and the regulation of the Wnt/ß-catenin pathway in pathophysiological processes.

  2018cites this paper
• PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients

  2018cites this paper
• Clinical performance of an analytically validated assay in comparison to microarray technology to assess PITX2 DNA-methylation in breast cancer

  2018cites this paper
• The Predictive Value of PITX2 DNA Methylation for High-Risk Breast Cancer Therapy: Current Guidelines, Medical Needs, and Challenges

  2017influential citation
• Novel approaches to early detection of endometrial cancer

  2017cites this paper
• Efecto de la sobre-expresión de DNMT3B en la actividad transcripcional de genes relacionados con el cáncer

  2017cites this paper
• Absolute quantification of DNA methylation using microfluidic chip-based digital PCR.

  2017cites this paper
• Epigenomic and Functional Characterization of Junctophilin 3 (JPH3) as a Novel Tumor Suppressor Being Frequently Inactivated by Promoter CpG Methylation in Digestive Cancers

  2017cites this paper
• Hypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients

  2017cites this paper
• Recent advances in HER2 positive breast cancer epigenetics: Susceptibility and therapeutic strategies.

  2017cites this paper
• MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors

  2017cites this paper
• Study on the Interaction of the CpG Alternating DNA with CdTe Quantum Dots

  2017cites this paper
• Phosphatidylserine: A cancer cell targeting biomarker.

  2017cites this paper
• Dynamics of LINE-1 retrotransposon methylation levels in circulating DNA from lung cancer patients undergoing antitumor therapy

  2017cites this paper
• The human epidermal growth factor receptor 2 (HER2) in the breast cancer : from measurement to targeted treatment

  2017cites this paper
• Clinical potential of TCF21 methylation in the diagnosis of renal cell carcinoma

  2016cites this paper
• The molecular characterization of the progression of oral squamous cell carcinoma

  2016cites this paper
• Transcription Factors, Transcriptional Coregulators, and Epigenetic Modulation in the Control of Pulmonary Vascular Cell Phenotype: Therapeutic Implications for Pulmonary Hypertension (2015 Grover Conference Series)

  2016cites this paper
• DAPK1 Promoter Methylation and Cervical Cancer Risk: A Systematic Review and a Meta-Analysis

  2015cites this paper
• Gene expression profiling of MYC-driven tumor signatures in porcine liver stem cells by transcriptome sequencing.

  2015cites this paper
• Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review)

  2015cites this paper
• Validation of new cancer biomarkers: a position statement from the European group on tumor markers.

  2015cites this paper
• TET1-mediated different transcriptional regulation in prostate cancer.

  2015cites this paper
• Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons.

  2015cites this paper
• Frei zirkulierende methylierte DNA als Tumormarker des kolorektalen Karzinoms

  2015cites this paper
• DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma

  2015cites this paper
• DNA Detection Technology Using Zinc Finger Protein

  2015cites this paper
• Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer

  2015cites this paper
• Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer

  2014cites this paper
• Linking Immunity, Epigenetics, and Cancer in Inflammatory Bowel Disease

  2014cites this paper
• Clonal intratumor heterogeneity of promoter hypermethylation in breast cancer by MS-MLPA

  2014cites this paper
• Associated analysis of DNA methylation for cancer detection using CCP-based FRET technique.

  2014cites this paper
• Tumor markers: a proteomic approach

  2014cites this paper
• Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphoma

  2013cites this paper
• Protocadherin 17 acts as a tumour suppressor inducing tumour cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers

  2013cites this paper
• Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients.

  2013cites this paper
• Blockade of DNA methylation enhances the therapeutic effect of gefitinib in non-small cell lung cancer cells.

  2013cites this paper
• In the Spotlight: Bioinformatics

  2013cites this paper
• The Prognostic Value of Epigenetic Silencing of p16 Gene in NSCLC Patients: A Systematic Review and Meta-Analysis

  2013cites this paper
• Prognostic role of methylated free circulating DNA in colorectal cancer

  2012cites this paper
• Methylated promoters of genes encoding protocadherins as a new cancer biomarker family

  2012cites this paper
• DNA methylation changes in prostate cancer.

  2012cites this paper
• Investigating the Role DNA Methylations Plays in Developing Hepatocellular Carcinoma Associated with Tyrosinemia Type 1 Using the Comet Assay

  2012cites this paper
• New primers for methylation-specific polymerase chain reaction enhance specificity of detecting STAT1 methylation.

  2012cites this paper
• DNA methylation biomarkers in cancer: progress towards clinical implementation

  2012cites this paper
• Population-based case–control study on DAPK1, RAR-β2 and MGMT methylation in liquid-based cytology

  2012cites this paper
• GSTP1 hypermethylation is associated with reduced protein expression, aggressive disease and prognosis in neuroblastoma

  2012cites this paper
• Promoter Methylation and Gene Expression Analysis in Prostate Cancer

  2012cites this paper
• A pyrosequencing assay for the quantitative methylation analysis of the PCDHB gene cluster, the major factor in neuroblastoma methylator phenotype

  2012cites this paper
• IGFBP7 promoter methylation and gene expression analysis in prostate cancer.

  2012cites this paper
• O(6)-Methylguanine-DNA methyltransferase (MGMT) in normal tissues and tumors: enzyme activity, promoter methylation and immunohistochemistry.

  2011cites this paper
• Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer.

  2011cites this paper
• Equivocal cytology in lung cancer diagnosis

  2011cites this paper
• Hypermethylation of multiple tumor-related genes associated with DMNT3b up-regulation served as a biomarker for early diagnosis of esophageal squamous cell carcinoma

  2011cites this paper
• Left-right asymmetry in embryonic development and breast cancer: common molecular determinants?

  2011cites this paper
• From DEPARTMENT OF ONCOLOGY AND PATHOLOGY Karolinska Institutet, Stockholm, Sweden SIGNALOMICS: UNSUPERVISED AND GLOBAL STRATEGIES TO EXPLORE MECHANISMS OF RADIORESISTANCE IN LUNG CANCER CELLS

  2011cites this paper
• Detection of Slit2 promoter hypermethylation in tissue and serum samples from breast cancer patients

  2011cites this paper
• Evaluation of methylation pattern in promoter region of E-cadherin gene and its relation to tumor grade and stage in breast cancer

  2011cites this paper
• RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer

  2011cites this paper
• Detection of DNA Hypermethylation as a Potential Biomarker for Prostate Cancer

  2011cites this paper
• Improving early breast cancer detection: focus on methylation.

  2011cites this paper
• Leukocyte DNA Methylation Signature Differentiates Pancreatic Cancer Patients from Healthy Controls

  2011cites this paper
• Cigarette Smoking and p16INK4α Gene Promoter Hypermethylation in Non-Small Cell Lung Carcinoma Patients: A Meta-Analysis

  2011cites this paper
• Methylation of the candidate biomarker TCF21 is very frequent across a spectrum of early‐stage nonsmall cell lung cancers

  2011cites this paper
• Molecular genetic markers in diagnosis of lung cancer

  2011cites this paper
• Biomarkers for Early Cancer Detection – Methodological Aspects

  2010cites this paper
• Assessing the DNA methylation status of single cells with the comet assay.

  2010cites this paper
• Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples

  2010cites this paper
• The epigenetics of breast cancer

  2010cites this paper
• Implications of cancer-associated systemic inflammation for biomarker studies.

  2010cites this paper
• DNA methylation biomarkers in serum for gastric cancer screening.

  2010cites this paper
• Polymorphisms of Glutathione-S-Transferase Genes and the Risk of Aerodigestive Tract Cancers in the Northeast Indian Population

  2010cites this paper
• Applicabillity of noninvasive biomarkers in prostate cancer diagnosis.

  2010cites this paper
• [Biomarkers of prostate cancer. A review].

  2010cites this paper
• Modifying the comet assay for measuring global DNA methylation in a variety of tissue cells

  2010cites this paper
• Evaluation of promoter hypermethylation detection in serum as a diagnostic tool for breast carcinoma in Korean women.

  2010cites this paper
• Homeobox gene IRX1 is a tumor suppressor gene in gastric carcinoma

  2010cites this paper
• Research Trends for Early Cancer Biomarker Detection in Italy: An Integrated Program in Oncology (PIO) Survey

  2010cites this paper
• Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples

  2010cites this paper
• Is endoscopic ultrasound "sound" for pancreatic cancer screening?

  2009cites this paper